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Aim To summarize available evidence on the role of host 
genetics in the susceptibility to congenital and childhood 
cytomegalovirus (CMV) infections by conducting a sys-
tematic review of published studies.
Methods We searched online databases (PubMed, Web of 
Science, Scopus and HuGe Navigator) for relevant studies 
with well-defined inclusion and exclusion criteria and as-
sessed the risk of bias using novel Confounding-Selection-
Information bias score (CSI).
Results 5105 studies were initially identified, but only 5 
met all the inclusion criteria and were analyzed in detail. 
Polymorphisms of the toll-like receptors (TLRs) and man-
nose-binding lectin (MBL) genes were shown to have an 
impact on the CMV infection in infants. Polymorphisms 
of the TLR2 (rs3804100, rs1898830), TLR4 (rs4986791), and 
TLR9 (rs352140) were shown to have a role in congenital 
CMV infection. Low MBL levels were associated with CMV 
infection in Chinese individuals, a finding that was not rep-
licated in Caucasians. The overall credibility of evidence 
was weak.
Conclusions Based on currently available very limited 
amount of evidence, it is uncertain whether congenital 
and childhood CMV infections are under host genetic con-
trol. Additional primary studies are needed with more spe-
cific research hypotheses that will enable gradual under-
standing of specific mechanisms of the CMV pathogenesis. 
More genetic studies in the future will facilitate better un-
derstanding of host susceptibility and likely enable novel 
preventative and curative measures.
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Human cytomegalovirus (CMV) is a DNA virus from the Her-
pesviridae family, characterized by a lifelong latency after the 
primary infection and occasional reactivations in the host. It 
is one of the most common human infections worldwide, 
with prevalence varying from 50% of younger to middle-
aged women in high-income countries to as much as 90% 
in low- and middle-income countries (1,2). Such high prev-
alence is caused by very effective transmission modalities, 
which include intrauterine, intrapartal, or postnatal cours-
es, as well as exchange through body fluids (3,4). Although 
most cases are asymptomatic, both in congenital and child-
hood infections, immunocompromised patients seem to be 
under the highest risk, where a CMV infection had been re-
ported in as much as 36% of critically ill patients. Additional 
risk factors included sepsis, transfusions, and the need for 
mechanical ventilation (5). However, it has been shown that 
life-threatening complications and life-long sequels in im-
munocompetent patients are not so rare and that the gas-
trointestinal and central nervous system were at the highest 
infection risk (6). Apart from that, CMV has been reported as 
the most frequent cause of congenital infections, with the 
prevalence of up to 6.1% (2). The highest risk of fetal infection 
with CMV occurs during the first half of pregnancy. Primary 
infections are transmitted more easily and cause congenital 
damage more frequently than the reactivations (4,7). About 
10%-15% of such primary infections turn out to be symp-
tomatic, with jaundice, hepatosplenomegaly, and thrombo-
cytopenia. Over half of these cases will develop neurological 
impairments, such as sensorineural hearing loss, vision dam-
age, or neurodevelopmental delay. The residual asymptom-
atic infections, which are more difficult to identify, can also 
cause these long-term, hampering impairments (1,3,4).
Childhood CMV infections, especially congenital infections, 
are a very serious public health issue. The socioeconomic 
impact of a CMV infection is still poorly recognized, even 
though it is more common than other congenital disorders 
and it is the major non-genetic cause of hearing loss in chil-
dren. The development of a CMV vaccine is a high priority 
as it would substantially reduce the patients’ suffering and 
the economic cost. It is vital to improve our knowledge and 
low awareness of congenital CMV since these represent 
main barriers to wider-scale improvements (8,9). The reason 
for low awareness is that a CMV infection in immunocom-
petent adults is usually asymptomatic or mild, thus a pri-
mary CMV infection is rarely diagnosed during pregnancy 
(10). Second, CMV infections may present with delayed on-
set sequelae (8). Another problem is that the transmission 
rate for congenital CMV infection is different regarding 
the maternal infection, where it can be up to 32% in 
primary and 1.4% in recurrent maternal infections (10). This 
suggests the hypothesis that maternal immunity provides 
protection against the congenital CMV infection. Another 
study has shown that the risk of congenital CMV infection 
was much higher among seropositive women, as it has 
been shown that the risk of reactivation or re-infection is 
much higher in seroprevalent populations (11).
Despite the high burden, there are still no existing effec-
tive vaccines. Therefore, preventive measures including 
prenatal and newborn screening for early CMV virus detec-
tion are encouraged. Better understanding of the disease 
pathogenesis is needed, including prevention of maternal 
infections and re-infections (8,11).
As it has become evident in the recent years that host ge-
netics plays an important role in susceptibility to various 
infectious diseases, and considering how widespread CMV 
infection is and which impact it may have on congenital 
development, the aim of this study was to perform system-
atic review of the available evidence of host genetics un-
derlying symptomatic CMV infection susceptibility in the 
congenital period and childhood.
MAterIAls AnD MethODs
literature search
We performed a detailed systematic search to summa-
rize published data related to the role of host genetics 
in susceptibility to CMV infection. Four sources of infor-
mation were used: PubMed (http://www.ncbi.nlm.nih.
gov/pubmed/), Web of Science (http://wok.mimas.ac.uk), 
Scopus (http://www.scopus.com), and HuGe Literature 
Finder (http://www.hugenavigator.net). The search was 
performed on July 20, 2014 (for search terms see Supple-
mentary Table 1) and an update was performed on No-
vember 2, 2015. Two reviewers independently categorized 
all identified articles for appropriateness by assessing the 
title and abstract and the third reviewer made the final 
selection to resolve any disagreements. Selected articles 
were read in full by two reviewers independently and eval-
uated to ensure appropriate qualifications of the inclusion 
and exclusion criteria. A third reviewer revised all the pa-
pers and confirmed adherence to inclusion criteria for the 
relevant articles. References of the finalized list of relevant 
articles were checked, and if any appropriate article was 
missed in the search strategy it was then included. System-
atic review was conducted and written under the PRISMA 
reporting guidelines (12).
323Gelemanović et al: Host genetics in childhood cytomegalovirus infection
www.cmj.hr
study selection
To be included in this systematic review, studies had to 
satisfy several requirements. First, we selected studies 
that investigated host genetic factors with susceptibility 
to congenital CMV infections or CMV infections in infants. 
Second, we were interested in studies based on biallelic 
single-nucleotide polymorphisms (SNP). We also limited 
the review to studies published in the English language. 
Exclusion criteria were animal (non-human) studies, stud-
ies based on other genetic marker types (short-tandem re-
peats or deletions), gene expression studies, adult-based 
studies, and in-vitro studies. Because of our focus on iso-
lated CMV susceptibility, we also excluded studies in which 
patients were reported to have various concomitant diag-
noses and other diseases, studies investigating congenital 
sensorineural hearing loss, and studies on CMV infection 
after any type of transplantation.
Data synthesis and quality assessment tool
Due to the low number of identified articles, we could 
not perform a quantitative synthesis, but rather three 
experienced reviewers described the main results and 
detected problems of each included study. Risk of bias 
in individual studies was assessed using the novel Con-
founding-Selection-Information bias score – CSI (13), the 
elements of which were developed on the basis of sev-
eral assessment scores, including Venice criteria for as-
sessing cumulative epidemiologic evidence in genetic 
associations (14), Newcastle-Ottawa case-control scale 
(15), Cochrane risk of bias tool (16), and previously estab-
lished quality scores in genetic epidemiology (17). Each 
of the three domains was graded according to credibil-
ity as high (A), intermediate (B), or weak (C). Since infor-
mation bias domain is divided into three sub-scores, the 
worst score defined the overall information bias risk. CSI 
scoring was done independently by two reviewers, while 
the third reviewer made the final decision in case of any 
discrepancies. Domains and explanation of CSI grades are 
listed in Supplementary Table 2.
results
eligible studies
4695 articles were acquired in the initial search. After dupli-
cates were removed, the title and abstract of 3797 unique 
tAble 1. list of full-text articles assessed for eligibility, with reasons for exclusion
Author, year title reasons for exclusion
Arav-Boger et al, 2012
 (40)
Polymorphisms in toll-like receptor genes influence antibody responses to 
cytomegalovirus glycoprotein B vaccine
Adult-based studies
Brown et al, 2009
 (41)




Di Bona et al, 2014
 (42)
HLA and killer cell immunoglobulin-like receptors influence the natural course of 
CMV infection
Adult-based studies
Hu et al, 2010
 (21)
Association between mannose-binding lectin gene polymorphism and pediatric 
cytomegalovirus infection
Included
Hurme and Helminen, 1998
 (43)
Resistance to human cytomegalovirus infection may be influenced by genetic 
polymorphisms of the tumor necrosis factor-alpha and interleukin-1 receptor 
antagonist genes
Adult-based studies
Jablonska et al, 2014
 (18)
Relationship between toll-like receptor 2 Arg677Trp and Arg753Gln and toll-like 
receptor 4 Asp299Gly polymorphisms and cytomegalovirus infection
Included
Muntasell et al, 2013
 (44)
NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell com-
partment redistribution in response to human cytomegalovirus
In vitro/expression 
studies
Szala et al, 2011
 (22)
Mannan-binding lectin-2 (MBL2) gene polymorphisms in prenatal and perinatal 
cytomegalovirus infections
Included
Taniguchi et al, 2013
 (19)
Polymorphisms in TLR-2 are associated with congenital cytomegalovirus (CMV) 
infection but not with congenital CMV disease
Included
Tao et al, 2012
 (27)
Genetic polymorphisms and serum levels of mannose-binding lectin in Chinese 
pediatric patients with common infectious diseases
Several diseases pooled 
together
Wujcicka et al, 2014
 (23)
Alterations in TLRs as new molecular markers of congenital infections with 
Human cytomegalovirus?
Review
Zheng et al, 2009
 (45)
The HLA-G 14 bp insertion/deletion polymorphism is a putative susceptible 
factor for active human cytomegalovirus infection in children
Wrong marker type
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articles were checked for inclusion criteria. The majority of 
potentially relevant articles were investigating host genet-
ics and susceptibility to CMV infection either after some 
type of transplantation (n = 26), in patients with another 
disease (n = 18), or in children with sensorineural hearing 
loss (n = 7). Among the sub-selected 12 articles (Table 1), 
only 4 articles met all the inclusion criteria and were con-
sidered to be relevant for this study (Figure 1). No further 
relevant articles were discovered in the reference check of 
the selected articles. Additional 410 articles were acquired 
in the updated search, but only 1 met all the inclusion cri-
teria (Figure 1). Key characteristics of the relevant studies 
are summarized in Table 2. All of the included studies were 
candidate gene case-control association studies. Selected 
studies were divided according to the investigated poly-
morphism with three studies based on toll-like receptors 
(TLRs) and two studies on the mannose-binding lectin gene 
(MBL). Also, 3 studies investigated genetic susceptibility to 
CMV infection, while 2 investigated susceptibility to con-
genital CMV infection. Risk bias of included studies accord-
ing to CSI scores is presented in Table 3, where all studies 
have at least one C grade and are considered to have weak 
credibility. Significant numerical findings from each indi-
vidual study are summarized in Table 4.
FIGure 1. search strategy flowchart, according to PrIsMA guidelines.
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studies referring to snPs in tlrs
The study by Jabłońska et al (18) investigated SNPs TLR2 
Arg677Trp (no reported rs identifier) and Arg753Gln 
(rs5743708), and TLR4 Asp299Gly (rs4986790) in 88 CMV-in-
fected infants and 28 healthy infants. All CMV-infected infants 
had the wild-type allele for TLR2 Arg677Trp. Approximately 
93% of infected infants did not have TLR2 Arg753Gln SNP and 
86% of infants did not have TLR4 Asp299Gly SNP. No signifi-
cant differences in frequency were observed between TLR2 
and TLR4 polymorphisms in infected and healthy infants (18).
In contrast, the study by Taniguchi et al (19) reported that 
congenital CMV infections were associated with polymor-
phisms of the TLR2 gene. The study involved 87 pediat-
ric cases with congenital CMV infection and 83 controls 
drawn from the database. Cases were grouped into dif-
ferent categories according to the disease severity and 
the onset of CMV infection. Five SNPs were chosen in the 
TLR2 (rs3804100, rs1898830), TLR4 (rs11536889), and TLR9 
(rs352139, rs352140) gene, which all had more than 5% 
prevalence in the common Japanese population. Results 
showed that the CC genotype of TLR2 rs3804100 and the 
tAble 2. Key elements of studies included in the systematic review (CMV – cytomegalovirus; TLR – toll-like receptors; MBL – mannose-
binding lectin; h-W equilibrium – hardy-Weinberg equilibrium)
Author, year
Gene 










88 infants with CMV 
infection
28 uninfected infants Caucasian not tested yes (for age and 
symptomatic 
infection)







87 infants with 
congenital CMV 
infection
83 controls taken from database 
as general population
Japanese yes no





18 fetuses and new-
borns with congeni-
tal CMV infection
19 uninfected newborns Caucasian yes no






104 children with 
CMV infection
105 uninfected children Chinese 
Han
yes no




103 neonates with 
CMV infection
230 uninfected neonates Caucasian not tested no
tAble 3. risk of bias according to CsI score of studies included in the systematic review (CsI – Confounding-selection-Information 
bias score; (q)PCr – (quantitative real-time)polymerase chain reaction; QC – quality control)
CsI explanation
Author, year score C (confounding bias) s (selection bias) I (information bias)
Jablonska et al, 
2014 (18)





I1:A-cases confirmed by antibody assay and PCR
I2:B-antibody negative controls
I3:A-genotyping QC reported
Taniguchi et al, 
2013 (19)
CBC C-no information 
whether controls 
were matched to 
cases
B-controls drawn from 
database (to represent 
general population)
I1:B-majority of cases confirmed by clinical status and urine-filter 
based screening, only few confirmed by PCR
I2:C-no description of disease status in controls
I3:A-genotyping QC reported
Wujcicka et al, 
2015 (20)




I1:A-cases confirmed by serological tests and qPCR
I2:C-not reported clearly how controls were confirmed as uninfected
I3:A-genotyping QC reported
Hu et al, 
2010 (21)





I1:A-cases confirmed by qPCR and antibody assay
I2:B-antibody negative controls
I3:C-no genotyping QC reported
Szala et al, 
2011 (22)
ABC A-no apparent 
confounding
B-hospital based I1:B-cases confirmed by qPCR and/or antibody assay
I2:C-not reported clearly how controls were confirmed as uninfected
I3:C-no genotyping QC reported
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AA genotype of TLR2 rs1898830 were significantly more 
frequent in infants with congenital CMV infection than in 
the general population. No significant difference was ob-
served in the frequency of TLR4 and TLR9, and no signifi-
cant association was found between different groups of 
infants with congenital CMV disease (19).
Another case-control study of congenital CMV infections 
and susceptibility to TLR4 and TLR9 by Wujcicka et al (20) 
sampled 18 infected fetuses and newborns and 19 con-
trol cases. Half of the infected cases showed symptomat-
ic disease. Two candidate genes were screened for asso-
ciation with congenital CMV infection – TLR4 (rs4986790, 
rs4986791) and TLR9 (rs352140). The main results of this 
study were that CC genotype at TLR4 rs4986791 and GA 
genotype at TLR9 rs352140 occurred more frequently 
among the infected fetuses and newborns, while no sig-
nificant difference was observed for TLR4 rs4986790. Tak-
ing into account the influence of multiple TLR4 and TLR9 
SNPs on the development of congenital CMV infection, 
this study showed that GCA haplotype at rs4986790, 
rs4986791, and rs352140, respectively, was significantly as-
sociated with CMV congenital infection (odds ratio [OR] 
6.5 × 1012, P ≤ 0.0001), and that ACA haplotype was more 
frequent among symptomatic CMV-infected cases than 
among asymptomatic cases (P ≤ 0.0001) (20).
studies referring to snPs in Mbl
Hu et al (21) genotyped 104 CMV-infected children 
and 105 healthy children for 4 polymorphisms in 
the MBL2 gene (rs11003125 -550H/L, rs7096206 -221Y/X, 
rs7095891 + 4P/Q, rs1800450 + 230A/B). No significant dif-
ference was found at the -221 and +230 site. For the -550 
region of the promoter, the H/L genotype was more fre-
quent in CMV patients, while the H/H genotype was more 
frequent in healthy controls. The frequency of the high-
MBL-level related genotype YA-type was much lower in 
patients, but the low-level related genotype XB-type was 
more frequent (21).
Szala et al (22) conducted a study to define the correlation 
between the MBL2 polymorphisms with perinatal and pre-
natal CMV infections. They included 103 CMV-infected and 
230 uninfected neonates, 59 out of which had mothers 
with CMV infection and 171 had CMV-uninfected moth-
ers. Results showed no significant difference in the poly-
morphic allele frequencies (A/O + O/O) or with genotypes 
associated with lower levels of MBL (LXPA + O/O), which 
usually results in the lower MBL protein levels in two con-
trol groups. The study also determined there were no sig-
nificant differences of allele frequencies for the carriers of 
MBL polymorphisms and for those lacking the MBL protein 
between the CMV-infected group and controls (22).
DIsCussIOn
This study represents the first systematic field synopsis of 
all published studies on host genetic factors and suscep-
tibility to congenital and childhood CMV infections. Cur-
rently, there is no reliable evidence to either confirm or ex-
clude the association between the tested candidate gene 
tAble 4. numerical findings from each individual study, only significant results showed (TLR – toll-like receptors; MBL – mannose-
binding lectin; Or – odds ratio, CI – confidence interval).
Gene (rs number), Frequency of significant genotype, %
Author, year significant genotype Or [95% CI] P Model Cases Controls




11.7 [1.42–96.30] 0.015 codominant  10.3  1.2
TLR2 (rs1898830),
AA
0.43 [0.21–0.88] 0.03 codominant  34.5 19.7









4.81 [1.14–20.25] 0.05 overdominant  77.8 42.1
Hu et al, MBL2 (rs11003125), H/H 0.28 [0.15-0.55] 0 NA  19.2 45.7
2010 (21) MBL2 (rs11003125), H/L 2.51 [1.44-1.40] 0.001 NA  56.8 34.3
high-MBL-level related 
genotype YA-type
0.54 [0.36-0.97] 0.002 NA  47.6 62.9
low-level related 
genotype XB-type
1.47 [1.10-1.95] 0.007 NA  58.7 40
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SNPs and CMV infection, due to lack of replication of initial 
findings and overall weak credibility of available evidence. 
This conclusion is based on a very limited number of stud-
ies, which prevented more advanced analysis and meta-
analysis. Each of the identified studies had a specific set of 
limitations, further contributing to heterogeneity and in-
ability to perform a synthesizing data analysis.
The available studies are based on the genes that were ex-
pected to have a role in the disease pathogenesis. TLRs are 
involved in the recognition of the surface glycoproteins of 
pathogens and activation of the immune system response. 
Numerous in vitro studies confirmed the role of TLRs in im-
munity to CMV infection and it was proven that TLR4 and 
TLR2 recognize CMV. TLR2 Arg753Gln (rs5743708) and TLR4 
Asp299Gly (rs4986790) are correlated with a higher risk 
of acquiring CMV infection and disease in transplant pa-
tients (23-26). TLR2 polymorphisms might have been in-
volved even in CMV transmission from infected mothers 
to the fetus (19). But, findings from infant studies on this 
polymorphism are contradictory. A study on Caucasian in-
fants showed no association since similar TLR genotype 
frequencies were observed in CMV-infected and healthy 
infants (18). Interestingly, an association was observed in 
adults, where wild-type TLR2 Arg677Trp SNP showed an 
increased risk and heterozygote TLR2 Arg677Trp (no re-
ported rs identifier) a decreased risk of CMV infection (18). 
On the other hand, SNPs rs3804100 and rs1898830 in TLR2 
were observed at a higher frequency in Japanese infants 
with congenital CMV infection (19). Reasons for these dif-
ferences might come either from ethnicity (Caucasian vs 
Japanese), the timing of CMV infection (perinatal vs con-
genital), or factors other than TLRs and infant’s functionally 
immature immune system that are responsible for high-
er susceptibility to CMV infection. Findings on TLR4 gene 
suggested that rs4986790 was not associated with con-
genital CMV infection in infants (18,20), but that it carries 
decreased the risk of CMV infection in adults (18). Results 
on TLR9 rs352140 showed no association with congenital 
CMV infection in one study on Japanese infants (19), while 
another study on Caucasian infants showed a significant-
ly higher risk in heterozygotes (20), a finding that should 
be taken with caution considering the very small number 
of cases. Another gene, MBL2, has been suggested, with 
studies that showed that heterozygotes (A/O, A being the 
wild type and O the three SNPs) and homozygotes (O/O) 
had decreased levels of MBL protein (21,27). In Chinese 
Han infants XB variant was associated with low MBL lev-
els, which represents an increased risk of either acquiring 
CMV infection or progressing to CMV disease in already se-
ropositive patients (21). In contrast, a study in Caucasian 
infants showed no significant association in the frequency 
of MBL2 haplotypes among infected and healthy infants 
(22).
CMV is a very interesting model for studies on host ge-
netics. First, it is a member of Herpesvirus family, which 
includes a fair share of latent infections, which may not 
show any symptoms, or symptoms may be triggered by 
immune system failures (28). In the case of a congenital 
infection, there is a much lower level of confounding risk, 
when compared to other infections because of the lack of 
adaptive immunity and relative unimportance of micro-
biomes interactions. However, this also suggests that fu-
ture studies should be based on dyadic analyses, taking 
into account both the newborn and the mother, in an at-
tempt to better understand disease pathogenesis. We also 
need to understand the difference between symptomatic 
infections and latent asymptomatic ones, in order to iden-
tify factors that distinguish these two phenomena. Also, it 
is very likely that different genes are involved in different 
clinical presentations. While one set of genes might be im-
portant for CMV susceptibility, it is very likely that a com-
pletely different set of genes might be important for its 
clinical presentation, which is more linked to the general 
response of the host to not just CMV, but to other simi-
lar pathogens as well. A comparative analysis might help 
us understand which genes are involved in which path-
ways, and thus enable better understanding of the disease 
and its mechanisms. This duality fits well with the proposal 
that there may be a large number of genetically suscepti-
ble and masked hosts in the primary immunodeficiencies 
(29-31). We must assume a much more complex genetic 
background for disease development than the majority of 
previous studies did, and use appropriate tools from the 
hypothesis-free domain, especially a genome-wide associ-
ation analysis (32). Even more interesting would be the de-
velopment of more advanced study designs, which might 
attribute to better understanding of the issue of infection 
and re-infection, infection timing, maternal involvement, 
or even the issue of why some seropositive patients do not 
develop clinically apparent disease (33-35). All these activi-
ties might fit in well with the recent efforts to develop a 
vaccine and reduce the overall CMV burden (36).
In order to methodologically improve primary studies and 
provide better evidence for genetic susceptibility to CMV 
infections, substantial methodological improvements 
must be made, both on the host side (newborn/child 
and maternal), as well as the pathogen side. First, 
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controls, selection, and diagnostics must be of the high-
est standard, as case-control study design is very sensitive 
to failures of appropriate management of controls. This is 
often seen in studies that report controls as apparently 
healthy subjects, without control for the latent and asymp-
tomatic infections. We also need to develop better bio-
markers for the disease status assessment (37) and enable 
the development of true infect-omics studies (38), based 
on novel high-throughput molecular methods. Better di-
agnostics is another important measure, coupled with in-
clusion of maternal information. Lastly, all future studies 
should adhere to the widely-accepted guidelines such as 
STREGA (39), and ideally, all the raw data should be made 
publicly available to facilitate the global use of data and 
advance progress in CMV pathogenesis understanding.
This systematic review has several limitations. First, we iden-
tified only 5 studies as the source of information, which 
does not allow for wider-scale analyses or for a quanti-
tative synthesis in the form of meta-analysis. In addition, 
there were only 2 or 3 studies per gene, providing only a 
very limited insight into the study question. The individual 
study sample sizes were also very low, substantially reduc-
ing analytical power. Another possible limitation lies in the 
quality of the studies and their methodology and we de-
tected some risk for bias in all the studies. The majority of 
studies on CMV, after database screening, were focused on 
post-transplantation status, which is additionally method-
ologically confounded by primary diagnosis and the pre-
transplant medication, therefore reducing comparability of 
studies. In addition, there were several studies which fo-
cused on outcomes of CMV infection such as hearing loss, 
which was not detected in all participants. This suggests 
yet another layer of complexity, which is probably partly 
affected by host genetics and which also reduces the com-
parability of these studies. For these reasons we narrowed 
our research question with fewest possible confounders 
and focused on CMV infection susceptibility in children 
and congenital cases.
In conclusion, it seems that the exact mechanisms of 
CMV infection and associated pathogenesis are by far 
more complex than we expected, and that we need to 
aim to provide answers for focused level hypotheses, and 
only then build the knowledge base and understanding 
of the disease as a whole. Further advancements are pos-
sible in better understanding of the molecular level and 
in immune domain, followed by the validation in hu-
man studies. In addition, a case of framework system-
atic review might serve as the hypothesis-genera-
tion source of information and help us understand CMV 
pathogenesis in much greater detail.
Funding This study was in part supported by the Croatian 
Science Foundation grant 8875 and 8445, the Kohler Glob-
al Scholarship to K.D. and the EU FP7 grant PREPARE (grant 
602525).
ethical approval Not required.
Declaration of authorship AG, KD and OP conceived the 
study idea. IK, IP, GK, and OP defined the search strategy 
and identified research hypotheses. AG and KD performed 
the search, while OP resolved possible conflicts of the data 
extraction process. AG, KD, and OP drafted the manuscript. 
All authors approved the final version and are held ac-
countable for the study integrity.
Competing interests OP is a statistics editor in the Croa-
tian Medical Journal. To ensure that any possible conflict of 
interest relevant to the journal has been addressed, this ar-
ticle was reviewed according to best practice guidelines of 
international editorial organizations. All authors have com-
pleted the Unified Competing Interest form at www.icmje.
org/coi_disclosure.pdf (available on request from the cor-
responding author) and declare: no support from any or-
ganization for the submitted work except for those clearly 
stated previously; no financial relationships with any or-
ganizations that might have an interest in the submitted 
work in the previous 3 years; no other relationships or ac-
tivities that could appear to have influenced the submit-
ted work.
references
1 Kenneson A, Cannon MJ. review and meta-analysis of the 
epidemiology of congenital cytomegalovirus (CMV) infection. rev 
Med Virol. 2007;17:253-76. Medline:17579921 doi:10.1002/rmv.535
2 anzieri tM, Dollard sC, bialek sr, Grosse sD. systematic 
review of the birth prevalence of congenital cytomegalovirus 
infection in developing countries. Int J Infect Dis. 2014;22:44-8. 
Medline:24631522 doi:10.1016/j.ijid.2013.12.010
3 Joseph A, Mahida n, Irving W, soo s. Congenital cytomegalovirus 
infection. Paediatr Child health (Oxford). 2014;24:255-9. 
doi:10.1016/j.paed.2013.10.005
4 Kim Cs. Congenital and perinatal cytomegalovirus infection. 
Korean J Pediatr. 2010;53:14-20. doi:10.3345/kjp.2010.53.1.14
5 Osawa r, singh n. Cytomegalovirus infection in critically 
ill patients: a systematic review. Crit Care. 2009;13:r68. 
Medline:19442306 doi:10.1186/cc7875
6 rafailidis PI, Mourtzoukou eG, Varbobitis IC, Falagas Me. severe 
cytomegalovirus infection in apparently immunocompetent 
329Gelemanović et al: Host genetics in childhood cytomegalovirus infection
www.cmj.hr
patients: a systematic review. Virol J. 2008; 5:47. Medline:18371229 
doi:10.1186/1743-422X-5-47
7 revello MG, Gerna G. Diagnosis and management of human 
cytomegalovirus infection in the mother, fetus, and newborn 
infant. Clin Microbiol rev. 2002;15:680-715. Medline:12364375 
doi:10.1128/CMr.15.4.680-715.2002
8 Manicklal s, emery VC, lazzarotto t, boppana sb, Gupta rK. 
the “silent” global burden of congenital cytomegalovirus. Clin 
Microbiol rev. 2013;26:86-102. Medline:23297260 doi:10.1128/
CMr.00062-12
9 Arvin AM, Fast P, Myers M, Plotkin s, rabinovich r. Vaccine 
development to prevent cytomegalovirus disease: report 
from the national Vaccine Advisory Committee. Clin Infect Dis. 
2004;39:233-9. Medline:15307033 doi:10.1086/421999
10 ludwig A, hengel h. epidemiological impact and disease burden 
of congenital cytomegalovirus infection in europe. euro surveill. 
2009;14:26-32. Medline:19317969
11 de Vries JJ, van Zwet eW, Dekker FW, Kroes AC, Verkerk Ph, Vossen 
AC. the apparent paradox of maternal seropositivity as a risk factor 
for congenital cytomegalovirus infection: a population-based 
prediction model. rev Med Virol. 2013;23:241-9. Medline:23559569 
doi:10.1002/rmv.1744
12 Moher D, liberati A, tetzlaff J, Altman DG. Preferred reporting 
items for systematic reviews and meta-analyses: the PrIsMA 
statement. Plos Med. 2009;6:e1000097. Medline:19621072 
doi:10.1371/journal.pmed.1000097
13 Patarcic I, Gelemanovic A, Kirin M, Kolcic I, theodoratou e, baillie 
KJ, et al. the role of host genetic factors in respiratory tract 
infectious diseases: systematic review, meta-analyses and field 
synopsis. sci rep. 2015;5:16119. Medline:26524966 doi:10.1038/
srep16119
14 Ioannidis JP, boffetta P, little J, O’brien tr, uitterlinden AG, 
Vineis P, et al. Assessment of cumulative evidence on genetic 
associations: interim guidelines. Int J epidemiol. 2008;37:120-32. 
Medline:17898028 doi:10.1093/ije/dym159
15 Wells GA, shea b, O’Connell D, Peterson J, Welch V, losos M, et al. 
the newcastle-Ottawa scale (nOs) for assessing the quality of 
nonrandomised studies in meta-analyses. 2013. 
16 higgins JPt, Green s. Cochrane handbook for systematic reviews 
of Interventions Version 5.1.0 [updated March 2011]. 2011. 
17 bogardus st Jr, Concato J, Feinstein Ar. Clinical epidemiological 
quality in molecular genetic research: the need for methodological 
standards. JAMA. 1999;281:1919-26. Medline:10349896 
doi:10.1001/jama.281.20.1919
18 Jablonska A, Paradowska e, studzinska M, suski P, nowakowska D, 
Wisniewska-ligier M, et al. relationship between toll-like receptor 
2 Arg677trp and Arg753Gln and toll-like receptor 4 Asp299Gly 
polymorphisms and cytomegalovirus infection. Int J Infect Dis. 
2014;25:11-5. Medline:24813591 doi:10.1016/j.ijid.2014.04.001
19 taniguchi r, Koyano s, suzutani t, Goishi K, Ito Y, Morioka I, 
et al. Polymorphisms in tlr-2 are associated with congenital 
cytomegalovirus (CMV) infection but not with congenital CMV 
disease. Int J Infect Dis. 2013;17:e1092-7. Medline:23906542 
doi:10.1016/j.ijid.2013.06.004
20 Wujcicka W, Paradowska e, studzińska M, Gaj Z, Wilczyński J, 
lesnikowski Z, et al. tlr9 2848 GA heterozygotic status possibly 
predisposes fetuses and newborns to congenital infection 
with human cytomegalovirus. Plos One. 2015;10:e0122831. 
Medline:25844529 doi:10.1371/journal.pone.0122831
21 hu Y, Wu D, tao r, shang s. Association between mannose-
binding lectin gene polymorphism and pediatric cytomegalovirus 
infection. Viral Immunol. 2010;23:443-7. Medline:20712489 
doi:10.1089/vim.2009.0109
22 szala A, Paradowska e, nowakowska D, swierzko As, 
Dzierzanowska-Fangrat K, sokolowska A, et al. Mannan-binding 
lectin-2 (Mbl2) gene polymorphisms in prenatal and perinatal 
cytomegalovirus infections. Mol Immunol. 2011;48:2203-6. 
Medline:21722964 doi:10.1016/j.molimm.2011.06.220
23 Wujcicka W, Wilczynski J, nowakowska D. Alterations in tlrs as 
new molecular markers of congenital infections with human 
cytomegalovirus? Pathog Dis. 2014;70:3-16. Medline:23929630 
doi:10.1111/2049-632X.12083
24 Cervera C, lozano F, saval n, Gimferrer I, Ibanez A, suarez b, et al. 
the influence of innate immunity gene receptors polymorphisms 
in renal transplant infections. transplantation. 2007;83:1493-500. 
Medline:17565323 doi:10.1097/01.tp.0000264999.71318.2b
25 Kang sh, Abdel-Massih rC, brown rA, Dierkhising rA, Kremers 
WK, razonable rr. homozygosity for the toll-like receptor 
2 r753Q single-nucleotide polymorphism is a risk factor for 
cytomegalovirus disease after liver transplantation. J Infect Dis. 
2012;205:639-46. Medline:22219347 doi:10.1093/infdis/jir819
26 Kijpittayarit s, eid AJ, brown rA, Paya CV, razonable rr. 
relationship between toll-like receptor 2 polymorphism and 
cytomegalovirus disease after liver transplantation. Clin Infect Dis. 
2007;44:1315-20. Medline:17443468 doi:10.1086/514339
27 tao r, hua CZ, hu YZ, shang sQ. Genetic polymorphisms and 
serum levels of mannose-binding lectin in Chinese pediatric 
patients with common infectious diseases. Int J Infect Dis. 
2012;16:e403-7. Medline:22444663 doi:10.1016/j.ijid.2012.01.014
28 lycke e. Virological aspects on herpesvirus infections. scand J 
Infect Dis suppl. 1985;47:9-15. Medline:3006235
29 Alcad’s A, Abel l, Casanova Jl. human genetics of infectious 
diseases: between proof of principle and paradigm. J Clin Invest. 
2009;119:2506-14. Medline:19729848 doi:10.1172/JCI38111
30 Alcaďs A, Quintana-Murci l, thaler Ds, schurr e, Abel l, Casanova 
J. life-threatening infectious diseases of childhood: single-gene 
inborn errors of immunity? Ann n Y Acad sci. 2010;1214:18-33. 
Medline:21091717 doi:10.1111/j.1749-6632.2010.05834.x
31 Casanova Jl, Abel l. human genetics of infectious diseases: 
a unified theory. eMbO J. 2007;26:915-22. Medline:17255931 
SYSTEMATIC REVIEW330 Croat Med J. 2016;57:321-30
www.cmj.hr
doi:10.1038/sj.emboj.7601558
32 Civelek M, lusis AJ. systems genetics approaches to understand 
complex traits. nat rev Genet. 2014;15:34-48. Medline:24296534 
doi:10.1038/nrg3575
33 Ikuta K, Minematsu t, Inoue n, Kubo t, Asano K, Ishibashi K, et 
al. Cytomegalovirus (CMV) glycoprotein h-based serological 
analysis in Japanese healthy pregnant women, and in neonates 
with congenital CMV infection and their mothers. J Clin Virol. 
2013;58:474-8. Medline:23916379 doi:10.1016/j.jcv.2013.07.004
34 Chiavarini M, bragetti P, sensini A, Cenci e, Castronari r, rossi MJ, et 
al. breastfeeding and transmission of cytomegalovirus to preterm 
infants. Case report and kinetic of CMV-DnA in breast milk. Ital J 
Pediatr. 2011;37:6. Medline:21247481 doi:10.1186/1824-7288-37-6
35 hayashi s, Kimura h, Oshiro M, Kato Y, Yasuda A, suzuki C, et al. 
transmission of cytomegalovirus via breast milk in extremely 
premature infants. J Perinatol. 2011;31:440-5. Medline:21164427 
doi:10.1038/jp.2010.150
36 harrison GJ. Current controversies in diagnosis, management, 
and prevention of congenital cytomegalovirus: updates for 
the pediatric practitioner. Pediatr Ann. 2015;44:e115-25. 
Medline:25996198 doi:10.3928/00904481-20150512-11
37 Palmiere C, Augsburger M. Markers for sepsis diagnosis in the 
forensic setting: state of the art. Croat Med J. 2014;55:103-14. 
Medline:24778096 doi:10.3325/cmj.2014.55.103
38 Polasek O. Future of biobanks - bigger, longer, and more 
dimensional. Croat Med J. 2013;54:496-500. Medline:24170729 
doi:10.3325/cmj.2013.54.496
39 little J, higgins JP, Ioannidis JP, Moher D, Gagnon F, von elm e, et 
al. strengthening the reporting of Genetic Association studies 
(streGA): an extension of the strObe statement. Plos Med. 
2009;6:e22. Medline:19192942 doi:10.1371/journal.pmed.1000022
40 Arav-boger r, Wojcik Gl, Duggal P, Ingersoll rG, beaty t, Pass rF, et 
al. Polymorphisms in toll-like receptor genes influence antibody 
responses to cytomegalovirus glycoprotein b vaccine. bMC res 
notes. 2012;5:140. Medline:22414065 doi:10.1186/1756-0500-5-
140
41 brown rA, Gralewski Jh, razonable rr. the r753Q Polymorphism 
Abrogates toll-like receptor 2 signaling in response to human 
Cytomegalovirus. Clin Infect Dis. 2009;49:e96-9. Medline:19814623 
doi:10.1086/644501
42 Di bona D, scafidi V, Plaia A, Colomba C, nuzzo D, Occhino C, et 
al. hlA and killer cell immunoglobulin-like receptors influence 
the natural course of CMV infection. J Infect Dis. 2014;210:1083-9. 
Medline:24737799 doi:10.1093/infdis/jiu226
43 hurme M, helminen M. resistance to human cytomegalovirus 
infection may be influenced by genetic polymorphisms of the 
tumour necrosis factor-alpha and interleukin-1 receptor antagonist 
genes. scand J Infect Dis. 1998;30:447-9. Medline:10066041 
doi:10.1080/00365549850161403
44 Muntasell A, lopez-Montanes M, Vera A, heredia G, romo n, 
Penafiel J, et al. nKG2C zygosity influences CD94/nKG2C receptor 
function and the nK-cell compartment redistribution in response 
to human cytomegalovirus. eur J Immunol. 2013;43:3268-78. 
Medline:24030638 doi:10.1002/eji.201343773
45 Zheng XQ, Zhu F, shi WW, lin A, Yan Wh. the hlA-G 14 bp 
insertion/deletion polymorphism is a putative susceptible factor 
for active human cytomegalovirus infection in children (vol 74, 
pg 317, 2009). tissue Antigens. 2009;74:465. doi:10.1111/j.1399-
0039.2009.01312.x
